These results, along with a previous report demonstrating that a little-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like habits in mice,2 support the concept of targeting ACKR3 as a novel way to modulate the opioid program, which could open up new therapeutic avenues for opioid-associated Diseases. Raise more healthy immune functionality: https://alexx951ska7.yourkwikimage.com/user